| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Longeveron Inc. is a biotechnology company currently in the clinical development stage, dedicated to pioneering cell-based therapies. These treatments are designed to address both age-related conditions and various critical, life-threatening illnesses. The company's primary investigational product is LOMECEL-B, a sophisticated cellular therapy. This product is created from medicinal signaling cells that are cultivated and expanded after being harvested from the bone marrow of healthy young adult donors. Longeveron is actively conducting Phase 1 …
Over the last 12 months, insiders at Longeveron Inc. have bought $0 and sold $0 worth of Longeveron Inc. stock.
On average, over the past 5 years, insiders at Longeveron Inc. have bought $249,767 and sold $684,189 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 11,766 shares for transaction amount of $0 was made by Locklear Lisa (Chief Financial Officer) on 2025‑08‑11.
| 2025-08-11 | Locklear Lisa | Chief Financial Officer | 11,766 – | $0 | $0 | +7.91% | ||
| 2025-08-11 | Baluch Khoso | director | 11,766 – | $0 | $0 | +7.91% | ||
| 2025-05-30 | Sale | Soffer Rock | director | 11,000 0.0739% | $1.25 | $13,750 | -35.48% | |
| 2025-05-29 | Sale | Soffer Rock | director | 10,000 0.0661% | $1.30 | $13,000 | -38.93% | |
| 2025-05-22 | Sale | Soffer Rock | director | 2,000 0.0128% | $1.32 | $2,640 | -42.03% | |
| 2025-05-16 | Sale | Hare Joshua | Chief Scientific Officer | 5,250 0.0346% | $1.40 | $7,367 | -43.03% | |
| 2024-12-02 | Sale | Baluch Khoso | director | 1,250 0.0084% | $2.07 | $2,588 | -32.04% | |
| 2024-04-11 | Hare Joshua | Chief Scientific Officer | 42,553 1.9683% | $2.35 | $100,000 | -8.91% | ||
| 2024-04-11 | Soffer Rock | director | 31,915 1.4762% | $2.35 | $75,000 | -8.91% | ||
| 2024-04-11 | Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 10,638 0.4921% | $2.35 | $24,999 | -8.91% | ||
| 2024-04-10 | Hare Joshua | Chief Scientific Officer | 106,383 4.4178% | $2.35 | $250,000 | -17.78% | ||
| 2024-04-10 | Soffer Rock | director | 106,383 4.4178% | $2.35 | $250,000 | -17.78% | ||
| 2024-01-10 | Ross Cathy | director | 5,000 0.0205% | $1.31 | $6,545 | -83.67% | ||
| 2023-12-29 | Baluch Khoso | director | 8,322 0.0349% | $1.43 | $11,915 | -84.15% | ||
| 2023-12-28 | PFEFFER JEFFREY | director | 10,000 0.0392% | $1.35 | $13,500 | -84.46% | ||
| 2023-12-28 | Baluch Khoso | director | 1,678 0.0068% | $1.40 | $2,342 | -84.46% | ||
| 2023-09-12 | Sale | Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 13,405 0.0782% | $3.00 | $40,215 | -80.84% | |
| 2023-09-12 | Locklear Lisa | Chief Financial Officer | 5,000 0.0292% | $3.00 | $15,000 | -80.84% | ||
| 2023-09-08 | Sale | Hare Joshua | Chief Scientific Officer | 50,000 0.294% | $3.00 | $150,000 | -78.80% | |
| 2023-09-07 | Sale | Hare Joshua | Chief Scientific Officer | 15,400 0.0906% | $3.00 | $46,200 | -78.71% |
| Hare Joshua | Chief Scientific Officer | 721796 23.7176% | $1.28M | 6 | 11 | +68.44% |
| Locklear Lisa | Chief Financial Officer | 250964 8.2464% | $446,715.92 | 2 | 0 | |
| Soffer Rock | director | 209034 6.8687% | $372,080.52 | 6 | 4 | +61.88% |
| Soffer Donald M | director | 153514 5.0443% | $273,254.92 | 1 | 0 | <0.0001% |
| Green Geoff | CEO | 139723 4.5912% | $248,706.94 | 1 | 0 | +76.64% |
| Lehr Paul T | General Counsel, Secretary | 116366 3.8237% | $207,131.48 | 1 | 0 | +100.9% |
| Baluch Khoso | director | 52516 1.7256% | $93,478.48 | 3 | 1 | |
| Clavijo James | CFO and Treasurer | 47303 1.5543% | $84,199.34 | 1 | 4 | +100.9% |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 19616 0.6446% | $34,916.48 | 1 | 1 | |
| PFEFFER JEFFREY | director | 15000 0.4929% | $26,700.00 | 1 | 0 | |
| Ross Cathy | director | 10000 0.3286% | $17,800.00 | 1 | 0 |
$6,974,678 | 45 | -14.98% | $4.63M | |
$29,645,465 | 28 | 8.09% | $6.48M | |
$63,749,694 | 24 | -12.24% | $6.4M | |
$287,718 | 15 | -41.45% | $5.68M | |
Longeveron Inc. (LGVN) | $1,246,170 | 12 | 65.67% | $5.42M |
| Increased Positions | 9 | +26.47% | 112,448 | +10.76% |
| Decreased Positions | 9 | -26.47% | 133,809 | -12.81% |
| New Positions | 5 | New | 70,619 | New |
| Sold Out Positions | 4 | Sold Out | 115,457 | Sold Out |
| Total Postitions | 34 | 0% | 1M | -2.04% |
| Vanguard Group Inc | $300.00 | 2.53% | 505,572 | +361,300 | +250.43% | 2025-09-30 |
| Geode Capital Management, Llc | $84.00 | 0.71% | 141,501 | 0 | 0% | 2025-09-30 |
| Ubs Group Ag | $38.00 | 0.32% | 63,982 | -20,153 | -23.95% | 2025-09-30 |
| Renaissance Technologies Llc | $34.00 | 0.28% | 56,600 | +56,600 | New | 2025-09-30 |
| State Street Corp | $27.00 | 0.23% | 45,380 | 0 | 0% | 2025-09-30 |
| Jane Street Group, Llc | $26.00 | 0.22% | 43,942 | +43,942 | New | 2025-09-30 |
| Capital Investment Advisory Services, Llc | $16.00 | 0.13% | 26,525 | 0 | 0% | 2025-09-30 |
| Commonwealth Equity Services, Llc | $15.00 | 0.13% | 25,155 | 0 | 0% | 2025-09-30 |
| Hamilton Point Investment Advisors, Llc | $13.00 | 0.11% | 22,446 | +22,446 | New | 2025-09-30 |
| Hrt Financial Lp | $10.00 | 0.09% | 17,257 | +17,257 | New | 2025-09-30 |